Research and experimental development on natural sciences and engineering
NODE PHARMA AS
Revenue 2024
NOK 11.2m
Operating profit
NOK −358,000
Equity
NOK 2.8m
Incorporated
2021
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 11.2m | |
| Total operating costs | 11.6m | |
| Operating profit (EBIT) | −358k | |
| Net financial items | 14k | |
| Profit for the year | −344k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 8.1m | |
| of which current assets | 6.7m | |
| Equity | 2.8m | |
| Total liabilities | 5.3m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.